|
The technology is available on the new MyLab™E85 GTS Edition that will be showcased together with the brand new MyLab™C30 GTS ultrasound system at the Esaote booth
LONDON, March 13, 2026 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging - ultrasound, dedicated magnetic resonance and medical IT, is reinforcing its position as a leading provider of advanced imaging and guided therapy solutions for urologists at the 41st Annual European Association of Urology (EAU) Congress, currently underway in London (13-16 March 2026).
Esaote presents its new and innovative technology dedicated to urology: the exclusive Prostate Attention Map (PAM), now available on the new MyLab™E85 GTS. Esaote will also present the new MyLab™C30 GTS, extending high image quality performance on a portable system that allow to meet different examination settings.
Throughout the Congress, Esaote (Booth N16) is showcasing a comprehensive portfolio designed to support diagnosis precision and intervention guidance in prostate care, with a strong focus on confidence, efficiency and clinical excellence. PAM Technology is at the core of this innovation, offering automatic analysis of prostate mpMRI volumes and identifying suspicious regions of interest, therefore assisting urologists on enhancing target guidance and decision making.
"PAM Technology is fully integrated into Esaote's UroFusion software," said Marta Daniel, Guided Therapy Product and Clinical Solutions Manager at Esaote. "Our UroFusion package is designed to provide focal guidance during prostate targeted biopsies. Thanks to A.I., urologists have a seamless workflow, with similar duration as a standard biopsy exam, while improving confidence and accuracy during their biopsy procedures."
During the congress Esaote is also actively participating in TP Biopsy and MRI-US Fusion hands-on sessions, guided by internationally recognised specialists and offering attendees the opportunity to experience the latest advances on UroFusion.
Esaote's presence at EAU 2026 – with the introduction of PAM Technology and the launch of two urology dedicated systems - marks a significant expansion of Esaote's Guided Therapy Solutions (GTS) line and highlights the Company's ongoing commitment to empowering urologists with reliable, intelligent and clinically relevant imaging solutions that provide advanced image quality, intuitive interaction and seamless fusion workflows in prostate care.
Esaote Group is a leader in medical imaging (ultrasound, MRI and diagnostic process management software). At the end of 2025, the Group counts 1,300 employees, half of which are based in Italy. With facilities in Genoa and Florence and its own production and research units in Italy and the Netherlands, Esaote is present in over 100 countries worldwide. www.esaote.com
The technology is available on the new MyLab™E85 GTS Edition that will be showcased together with the brand new MyLab™C30 GTS ultrasound system at the Esaote booth
LONDON, March 13, 2026 /PRNewswire/ -- Esaote Group, a leading Italian innovator in medical imaging - ultrasound, dedicated magnetic resonance and medical IT, is reinforcing its position as a leading provider of advanced imaging and guided therapy solutions for urologists at the 41st Annual European Association of Urology (EAU) Congress, currently underway in London (13-16 March 2026).
Esaote presents its new and innovative technology dedicated to urology: the exclusive Prostate Attention Map (PAM), now available on the new MyLab™E85 GTS. Esaote will also present the new MyLab™C30 GTS, extending high image quality performance on a portable system that allow to meet different examination settings.
Throughout the Congress, Esaote (Booth N16) is showcasing a comprehensive portfolio designed to support diagnosis precision and intervention guidance in prostate care, with a strong focus on confidence, efficiency and clinical excellence. PAM Technology is at the core of this innovation, offering automatic analysis of prostate mpMRI volumes and identifying suspicious regions of interest, therefore assisting urologists on enhancing target guidance and decision making.
"PAM Technology is fully integrated into Esaote's UroFusion software," said Marta Daniel, Guided Therapy Product and Clinical Solutions Manager at Esaote. "Our UroFusion package is designed to provide focal guidance during prostate targeted biopsies. Thanks to A.I., urologists have a seamless workflow, with similar duration as a standard biopsy exam, while improving confidence and accuracy during their biopsy procedures."
During the congress Esaote is also actively participating in TP Biopsy and MRI-US Fusion hands-on sessions, guided by internationally recognised specialists and offering attendees the opportunity to experience the latest advances on UroFusion.
Esaote's presence at EAU 2026 – with the introduction of PAM Technology and the launch of two urology dedicated systems - marks a significant expansion of Esaote's Guided Therapy Solutions (GTS) line and highlights the Company's ongoing commitment to empowering urologists with reliable, intelligent and clinically relevant imaging solutions that provide advanced image quality, intuitive interaction and seamless fusion workflows in prostate care.
Esaote Group is a leader in medical imaging (ultrasound, MRI and diagnostic process management software). At the end of 2025, the Group counts 1,300 employees, half of which are based in Italy. With facilities in Genoa and Florence and its own production and research units in Italy and the Netherlands, Esaote is present in over 100 countries worldwide. www.esaote.com
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Esaote at EAU 2026: Introducing Exclusive PAM Technology to Advance Precision in Urological Imaging
SAN FRANCISCO, April 30, 2026 /PRNewswire/ -- Dreame Technology, a global leader in smart home appliances and health technology, today held its "DREAME NEXT" themed launch event at the Palace of Fine Arts in San Francisco.
Dreame stated that this launch event aims to redefine the next generation of lifestyle, serving as the prologue to the next decade of Dreame Technology's long-term development from a global perspective.
Among the new products, the Dreame Ring series stood out as one of the highlights of the event.
In terms of product design, the Dreame Ring achieves a breakthrough in wearing experience. It features an aviation-grade titanium alloy outer ring and a hypoallergenic epoxy resin inner ring, ensuring durability and texture while greatly enhancing skin-friendly comfort. With a thickness of just 2.5 millimeters and a weight as low as 2.6 grams, the ring delivers an almost "unnoticeable" wearing experience.
This design effectively solves the common problem of traditional smart wearables being abandoned due to discomfort, allowing users to wear the ring all day – including while sleeping – so that health observation and smart reminders become seamlessly integrated into daily life.
Three Product Lines: Deep Integration of Function and Aesthetics
The Dreame Ring series announced today includes three core products:
The first product is the Dreame AI Smart Ring. It features an ultra-compact world-leading vibration motor, pioneering refined fingertip haptic feedback technology, and integrates multiple sensors within an industry-leading ultra-thin design of just 2.5 millimeters. It provides vibrating alerts for various reminders, such as prolonged sitting, hydration, medication, and other notifications.
The second is the Dreame AI NFC Smart Ring, which serves as an "ecosystem key" by integrating access cards, keys, and digital passes for seamless connectivity.
The third is the Dreame Glow Ring, which continuously monitors heart rate, blood oxygen, body temperature, respiratory rate, and sleep structure around the clock, providing efficient sleep analysis, activity tracking, and health risk assessment.
High-Luxury Jewelry System: From Everyday Wear to Heirloom Collection
In terms of product positioning, Dreame plans to introduce high-luxury jewelry materials into its ring lineup, featuring 18K gold (yellow, white, and rose gold) and Pt950 platinum, paired with natural diamonds and precious gemstones such as sapphires, rubies, and emeralds, with support for personalized customization. The craftsmanship includes hollow carving, compound stone setting, and traditional hand-engraving techniques, with each piece finished by hand-polishing.
Dreame stated that the future direction of wearable devices is not to emphasize the presence of technology, but to allow technology to serve users invisibly. The AI high-luxury smart ring is the embodiment of this trend – it is no longer a device that needs to be "used," but an intelligent presence that accompanies users over the long term.
About Dreame Technology
Established in 2017, Dreame Technology is a global leader in high-end consumer electronics and intelligent manufacturing with the vision to empower lives through technology. Follow us on Facebook, Instagram, TikTok and Twitter. For more information, please visit https://www.dreametech.com/.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Dreame Technology's "DREAME NEXT" Smart Wearables: Smart Ring Comes Under the Spotlight
